Nils Löfgren

Nils Löfgren has a diverse work experience spanning over several years. Nils is currently the Chief Executive Officer at Nanolyze, a startup company focused on nanoparticle analysis. Nils'srole involves defining strategies to target the company's vision and developing a solid commercial plan.

Prior to their current position, Löfgren founded Happy Dane in 2019. Nils also worked as a Business Developer at GU Ventures, supporting companies in their growth and prosperity based on research results from the University of Gothenburg.

Löfgren has extensive experience in the clinical research industry. Nils previously served as the Vice Managing Director at Larix, a full-service Clinical CRO, where they played a crucial role in integrating Larix into the ALTEN group. Nils also held various roles at ALTEN Sweden, including KAM Life Science Nordics, Business Unit Manager Pharma, and KAM Life Science Sweden.

Earlier in their career, Löfgren worked at Alten as a Technical Unit Manager at Embedded Systems and as a Consultant in signal processing and biomedical engineering. Nils also served as a System Engineer at Neoventa Medical.

Löfgren's educational background includes a PhD in remote consultation and neonatal EEG signal processing from Chalmers University of Technology. Nils also worked as a Post Doc at Högskolan i Borås, where they conducted research, managed projects, and supervised students.

From 1994 to 1998, Nils Löfgren studied at Chalmers University of Technology, obtaining a Master of Science (MSc) degree in Electrical and Electronics Engineering.